Bidding 3-7 Jan 2025, price band ₹80–85, lot 1600 shares.
| Date | GMP (₹) | Est. Listing Price (₹) | Est. Listing Gain |
|---|---|---|---|
| 30 Sep | ₹0 | ₹85 | 0.00% |
| 29 Sep | ₹0 | ₹85 | 0.00% |
| 28 Sep | ₹2 | ₹87 | 2.35% |
| 27 Sep | ₹20 | ₹105 | 23.53% |
| 26 Sep | ₹35 | ₹120 | 41.18% |
| 25 Sep | ₹35 | ₹120 | 41.18% |
| 24 Sep | ₹35 | ₹120 | 41.18% |
| 23 Sep | ₹0 | ₹85 | 0.00% |
After allotment
| Category | Times | Est. Allotment Chances* |
|---|---|---|
| HNIs (Total) | 1.96 | 51.0% |
| bHNI | 1.65 | 60.6% |
| sHNI | 2.58 | 38.8% |
| QIBs | 2.02 | - |
| Retail | 2.06 | 48.5% |
| Employees | 2.01 | 49.8% |
*Rough estimate: 1 ÷ times subscribed. Retail and HNI allotment is by lottery, so actual odds depend on the number of applications.
Fabtech specializes in manufacturing and providing design-to-validation solutions for cleanrooms in the pharmaceuticals, healthcare, and biotech sectors. They offer custom modular panels, HVAC systems, and more. With certifications, strategic investments, and key clients like Unichem Laboratories and Aurobindo Pharma, Fabtech is expanding its capabilities, including a recent acquisition in HVAC. The company, part of the Fabtech Group, has seen steady revenue and profit growth, with a strong focus on operational efficiency.